INX Inc (NASDAQ:INXI) achieved its new 52 week high price of $8.63 where it was opened at $8.61 UP 0.01 points or +0.12% by closing at $8.61. INXI transacted shares during the day were over 11,892 shares however it has an average volume of 156,805 shares.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/?p=6394

Arbinet Corporation (NASDAQ:ARBX) reported that their respective boards of directors have scheduled special meetings of their respective stockholders for Friday, February 25, 2011 to vote on matters incident to the proposed transaction announced by the companies on November 11, 2010.

Cleveland BioLabs, Inc. (NASDAQ:CBLI) previously reported that CBLB502, a drug under development to treat exposure to radiation, has been granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.